Middle East Respiratory Syndrome Coronavirus during Pregnancy, Abu Dhabi, United Arab Emirates, 2013

As of June 19, 2015, the World Health Organization had received 1,338 notifications of laboratory-confirmed infection with Middle East respiratory syndrome coronavirus (MERS-CoV). Little is known about the course of or treatment for MERS-CoV in pregnant women. We report a fatal case of MERS-CoV in a...

Full description

Saved in:
Bibliographic Details
Published in:Emerging infectious diseases 2016-03, Vol.22 (3), p.515-517
Main Authors: Malik, Asim, El Masry, Karim Medhat, Ravi, Mini, Sayed, Falak
Format: Article
Language:English
Subjects:
Adult
Antiviral Agents - therapeutic use
Coronavirus Infections - diagnosis
Coronavirus Infections - drug therapy
Coronavirus Infections - epidemiology
Coronavirus Infections - history
Coronavirus Infections - virology
Dispatch
Drug Therapy, Combination
Fatal Outcome
Female
Health aspects
History, 21st Century
Humans
Interferon
MERS-CoV
Middle East respiratory syndrome coronavirus
Middle East Respiratory Syndrome Coronavirus - classification
Middle East Respiratory Syndrome Coronavirus - genetics
Middle East Respiratory Syndrome Coronavirus during Pregnancy, Abu Dhabi, United Arab Emirates, 2013
Pregnancy
Pregnancy Complications, Infectious - diagnosis
Pregnancy Complications, Infectious - drug therapy
Pregnancy Complications, Infectious - epidemiology
Pregnancy Complications, Infectious - history
Pregnancy Complications, Infectious - virology
Pregnant women
UAE
United Arab Emirates - epidemiology
WHO
World Health Organization
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:As of June 19, 2015, the World Health Organization had received 1,338 notifications of laboratory-confirmed infection with Middle East respiratory syndrome coronavirus (MERS-CoV). Little is known about the course of or treatment for MERS-CoV in pregnant women. We report a fatal case of MERS-CoV in a pregnant woman administered combination ribavirin-peginterferon-α therapy.
ISSN:1080-6040
1080-6059
DOI:10.3201/eid2203.151049